Sage Therapeutics, Inc. Operating Lease Liability
Sage Therapeutics, Inc. had Operating Lease Liability of $11.84 million as of 2024-12-31, per its 10-K filed 2025-02-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-02-11
- 2024-12-31: Operating Lease, Liability $11.84M.
- 2024-09-30: Operating Lease, Liability $10.27M.
- 2023-12-31: Operating Lease, Liability $5.17M.
- 2022-12-31: Operating Lease, Liability $12.13M.
| Period end | Operating Lease, Liability |
|---|---|
| 2024-12-31 | $11.84M 10-K · filed 2025-02-11 |
| 2024-09-30 | $10.27M 10-Q · filed 2024-10-29 |
| 2023-12-31 | $5.17M 10-K · filed 2025-02-11 |
| 2022-12-31 | $12.13M 10-K · filed 2024-02-14 |
| 2021-12-31 | $18.43M 10-K · filed 2023-02-16 |
| 2020-12-31 | $28.10M 10-K · filed 2022-02-24 |
| 2019-12-31 | $37.09M 10-K · filed 2021-02-24 |
| 2019-09-30 | $38.92M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $40.70M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $41.68M 10-Q · filed 2019-05-02 |
| 2019-01-01 | $44.20M 10-Q · filed 2019-11-12 |